← Leaderboards
Christopher James Gibson
Dana-Farber Cancer Inst
$659,712
Attributed
$659,712
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $219.9K · FY2021–23$250K$187.5K$125K$62.5K$0
'21
'22
'23
Funding mix
By agency
NIH$659,712 · 1
By mechanism
K08$659,712 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Benjamin Levine Ebert$26,802,844
- Kira Gritsman$6,960,355
- Alan David D'andrea$28,094,196
- Constantine S. Mitsiades$5,369,219
- Wayne A. Marasco$43,896,916
Others in their field
Other Emerging Leaders on “Acute Myelocytic Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Leonard Freedman · Leidos Biomedical Research, Inc.$12,430,568
- Crystal Mackall · Children'S Hosp Of Philadelphia$6,450,142
- Christopher A Miller · Washington University$5,424,298
- Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst$5,329,699
- Kelly Diringer Getz · University Of Pennsylvania$4,068,250
Research focus
Acute Myelocytic LeukemiaAdvisory CommitteesAdverse OutcomeAge RelatedAllogenicAreaAffectBiological ProcessBiologic CharacteristicBiologyBiometryBone MarrowCancer CellCardiovascular DiseasesCareerCareer DevelopmentCaringCellsCell TypeCharacteristicsClonal EvolutionClonal ExpansionCollaborationsCommunities
Grant awards (3)
The Impact of Donor Hematopoietic DNMT3A Mutations in Stem Cell Transplant Recipients$219,904
K08 · FY2023 · CA · contact PI
The Impact of Donor Hematopoietic DNMT3A Mutations in Stem Cell Transplant Recipients$219,904
K08 · FY2022 · CA · contact PI
The Impact of Donor Hematopoietic DNMT3A Mutations in Stem Cell Transplant Recipients$219,904
K08 · FY2021 · CA · contact PI